NCT01865045View on ClinicalTrials.gov

Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2017

Conditions
Malignant Pleural Mesothelioma
Trial Locations (1)

20089

Istituto Clinico Humanitas, Rozzano

All Listed Sponsors
lead

Armando Santoro, MD

OTHER

NCT01865045 - Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients | Biotech Hunter | Biotech Hunter